Glaukos (GKOS) Gross Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 231.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.00 |
| Dec 31, 2025 | -7,688.00 |
| Sep 30, 2025 | 207.00 |
| Jun 30, 2025 | 287.00 |
| Mar 31, 2025 | 241.00 |
| Dec 31, 2024 | -412.00 |
| Sep 30, 2024 | -279.00 |
| Jun 30, 2024 | -82.00 |
| Mar 31, 2024 | 81.00 |
| Dec 31, 2023 | 381.00 |
| Sep 30, 2023 | 394.00 |
| Jun 30, 2023 | 4,366.00 |
| Mar 31, 2023 | 3,433.00 |
| Dec 31, 2022 | -3.00 |
| Sep 30, 2022 | -1,049.00 |
| Jun 30, 2022 | -1,110.00 |
| Mar 31, 2022 | -1,205.00 |
| Dec 31, 2021 | -986.00 |
| Sep 30, 2021 | -688.00 |
| Jun 30, 2021 | -847.00 |
| Mar 31, 2021 | -1,005.00 |
| Dec 31, 2020 | -1,563.00 |
| Sep 30, 2020 | -1,351.00 |
| Jun 30, 2020 | -5,529.00 |
| Mar 31, 2020 | -4,436.00 |
| Dec 31, 2019 | -965.00 |
| Sep 30, 2019 | -3.00 |
| Jun 30, 2019 | 183.00 |
| Mar 31, 2019 | 35.00 |
| Dec 31, 2018 | 456.00 |
| Sep 30, 2018 | 377.00 |
| Jun 30, 2018 | 421.00 |
| Mar 31, 2018 | 463.00 |
| Dec 31, 2017 | 2,353.00 |
| Sep 30, 2017 | 437.00 |
| Jun 30, 2017 | 770.00 |
| Mar 31, 2017 | 914.00 |